Patents by Inventor Brian Brandell

Brian Brandell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050209518
    Abstract: A self-calibrating monitoring system based on microdialysis for measurement of a body analyte is disclosed. In one embodiment, perfusate containing a known concentration of body analyte is mixed with an enzyme solution after passing through a microdialysis needle and instead of passing through the microdialysis needle to measure the body analyte and to calibrate the analysis chamber that measures the body analyte.
    Type: Application
    Filed: March 16, 2005
    Publication date: September 22, 2005
    Inventors: Burton Sage, David Gillett, Brian Brandell
  • Patent number: 6285909
    Abstract: A method and a system for preserving patient specific data in implantable pulse generator systems. A communication link is established with a first implantable pulse generator. Electronic cardiac data contained within the first implantable pulse generator is retrieved through the communication link. The electronic cardiac data is then electronically downloaded to a second implantable pulse generator. Prior to downloading, the electronic cardiac data can be formatted into a format compatible with the second implantable pulse generator.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: September 4, 2001
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Robert J. Sweeney, Brian Brandell, Bruce H. KenKnight
  • Patent number: 6068651
    Abstract: An implantable atrial defibrillator for converting atrial arrhythmias into normal sinus rhythm includes a patient activated mode, a programmable safety timer, and means for deactivating the patient activated mode. The programmable safety timer starts counting down when AF is detected. If the safety timer times out before the patient activates delivery of an atrial defibrillation shock, the device will deactivate the atrial defibrillation function, and will not allow an atrial defibrillation shock to be delivered until the physician reactivates it with a programmer. This allows the physician to administer anticoagulants to the patient prior to atrial cardioversion. The preferred length of time between AF detection and lock out of the atrial defibrillation function is 24 hours.
    Type: Grant
    Filed: March 26, 1998
    Date of Patent: May 30, 2000
    Assignee: Pacesetter, Inc.
    Inventor: Brian Brandell